Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. Our Integrated Drug Creation platform powers cutting-edge de novo AI models and AI lead optimization models aimed at designing better biologics against difficult-to-drug targets.

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create...

Absci is a data-first generative AI drug creation company unlocking novel biology through generative AI. Our Integrated Drug Creation™ Platform powers cutting-edge de novo AI and lead optimization models aimed at designing better biologics against difficult-to-drug targets.

2 天之前 · Absci anticipates initiation of a Phase 1 clinical trial for ABS-201 in early 2026. ABS-301 (potential first-in-class antibody for undisclosed immuno-oncology target): ABS-301 is a fully human antibody designed to bind to a novel target discovered through Absci's Reverse Immunology platform. Absci recently presented data for this program ...

5 天之前 · Get a real-time Absci Corporation (ABSI) stock price with an overview of financials, statistics, forecasts, charts and more.

1 天前 · Absci Corporation. Unveiled updates across proprietary pipeline and demonstrated new breakthroughs by AI platform at 2024 R&D Day. Entered into collaboration with AMD, including $20 million ...

2025年3月13日 · Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech...

1 天前 · About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.

At Absci we don't just believe in the impossible, we're making it a reality. Join us at the cutting edge of generative AI and drug discovery in pursuit of our mission to create better biologics for patients, faster.

1 天前 · Absci Corporation (NASDAQ:ABSI) Q4 2024 Earnings Conference Call March 18, 2025 4:30 PM ETCompany ParticipantsAlex Khan - VP of Finance and IRSean McClain -...